Expert warns of limitations of new MCI, Alzheimer's criteria

02/6/2012 | MolecularImaging.net

The revised criteria for the diagnosis of mild cognitive impairment, as determined by the National Institute on Aging and the Alzheimer's Association last year, are too broad in terms of what constitutes functional independence and "thus blur the categorical distinction between MCI and dementia," Dr. John C. Morris from Washington University in St. Louis wrote in an analysis published in Archives of Neurology. Morris expressed concern that the guidelines would compromise the diagnosis of Alzheimer's disease dementia. "It is now time to advance AD patient care and research by accepting that 'MCI due to AD' is more appropriately recognized as the earliest symptomatic stage of AD," he wrote.

View Full Article in:

MolecularImaging.net

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
PacificSource
OR
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Counsel I – Clinical Contracts
Gilead Sciences
Foster City, CA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Vice President, Idaho Regional Director
PacificSource
Boise, ID